Market Place
Sourcing Support
Instil`s PD-L1xVEGF Bispecific Shows Promise in China
31 Jul 2025 //
FIERCE BIOTECH
ImmuneOnco Shares Early IMM2510 NSCLC Trial Data in China
31 Jul 2025 //
GLOBENEWSWIRE
Instil Bio gets US FDA clearance for AXN-2510 Phase 1 trial
02 Jul 2025 //
GLOBENEWSWIRE
Instil Bio & ImmuneOnco to Host Investor Breakfast at 2025 ASCO
23 May 2025 //
GLOBENEWSWIRE
Instil, ImmuneOnco’s NSCLC Trial on Track for Q3 2025 Completion
22 May 2025 //
GLOBENEWSWIRE
Instil Bio Reports China Progress For PD-L1xVEGF Antibody IMM2510
14 Jan 2025 //
GLOBENEWSWIRE
Instil Bio Reports Q3 2024 Financial Results & Corporate Update
13 Nov 2024 //
GLOBENEWSWIRE
Instil Bio And ImmuneOnco Announce PD-L1xVEGF Strategy
16 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.